Source: International Congress 2015 – Iatrogenic drug



Rating:

Share or cite this content

Citations should be made in the following way:
Maureen Horton (Baltimore, United States of America). Emerging biologicals: separating drug-related injury from the underlying disease-related lung injury. International Congress 2015 – Iatrogenic drug

Member's Comments

No comment yet.

Related content which might interest you: Snake venom leads to injury similar to acute lung injury revealing the needing of anti-inflammatory therapy Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Acute lung injury and ILDs: biological and pathological bases  Source: International Congress 2017 – PG11 Acute interstitial lung diseases (ILD) Year: 2017 Mechanisms of acute lung injury Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases Year: 2004 Acute lung injury as a possible adverse drug reaction related to gefitinib Source: Eur Respir J 2002 Jan 01;22(1):179-181 Year: 2003 Can kidney injury cause lung injury? Source: Annual Congress 2013 –"Liaisons Dangereuses": the lung and other organs Year: 2013 Ventilator-associated lung injury: a search for better therapeutic targets Source: Eur Respir J 2007; 30: 1216-1226 Year: 2007 Predicting lung injury Source: International Congress 2014 – Acute respiratory distress syndrome (ARDS): the role of prevention Year: 2014 The role of CD74 in experimental and clinical acute lung injury Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Mechanisms of early lung injury Source: Research Seminar 2010 - Managing the lung of the extremely low gestational age neonate (ELGAN) in the delivery room Year: 2010 Acute lung injury: how the lung inflammatory response works Source: Eur Respir J 2003; 22: 22S-23S Year: 2003 New concepts in the pathogenesis of acute lung injury - an overview Source: Annual Congress 2003 - Pathogenesis of acute lung injury - new insights and targets for intervention Year: 2003 Murine models of cardiovascular damage in lung diseases Source: Eur Respir Monogr 2020; 88: 31-46 Year: 2020 Modelling acute lung injury: infections versus bacterial components Source: Annual Congress 2012 - PG4 Experimental models for respiratory medicine: strengths and limitations Year: 2012 Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Human small airway-on-a-chip: A novel microphysiological system to model lung inflammation, accelerate drug development and enable inhalational toxico-analysis Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes Source: Eur Respir J, 55 (1) 1900647; 10.1183/13993003.00647-2019 Year: 2020 Modeling resolution of direct acute lung injury Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011